Ignite Creation Date:
2025-12-24 @ 2:30 PM
Ignite Modification Date:
2026-02-02 @ 4:37 PM
Study NCT ID:
NCT06663059
Status:
RECRUITING
Last Update Posted:
2024-10-29
First Post:
2024-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
Sponsor:
Organization: